Cumberland Pharmaceuticals Inc
CPIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001087294
No open-market purchases or sales by Cumberland Pharmaceuticals Inc insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $16.0M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Cumberland Pharmaceuticals Inc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 17 | 23 | +6 |
| Shares | 2.45M | 2.49M | +46.7K (+1.9%) |
| Value | $5.89M | $5.61M | −$286.7K (−4.9%) |
New holders (6)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 29,122 | $65.5K | 0.00% |
| Millennium Management LLC | 20,376 | $46.0K | 0.00% |
| True Capital Management | 12,025 | $27.1K | 0.02% |
| UBS Group AG | 3,723 | $8.38K | 0.00% |
| Bank of America Corp | 9 | $20 | 0.00% |
| Simplex Trading, LLC | 97 | $0 | 0.00% |
Sold out (0)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q3 2022 and filed for Q4 2022 without it.
None.